Healthy volunteers help test new drug interaction with cholesterol medication
NCT ID NCT07097831
First seen Jan 11, 2026 · Last updated May 16, 2026 · Updated 21 times
Summary
This study looked at how a new drug, HRS-1301, changes the way the body processes a common cholesterol-lowering medicine (rosuvastatin). Sixteen healthy adults took both drugs in a fixed order, and researchers measured drug levels in the blood. The goal was to gather safety and interaction data, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215004, China
Conditions
Explore the condition pages connected to this study.